Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Five-time Olympic gold medal swimmer Missy Franklin was at the top of her sport when a shoulder injury forced her to retire. After that, her father was diagnosed with a rare kidney disease that forced her family to come together to support him. Now Franklin is working with Otsuka Pharmaceutical to raise awareness of genetic diseases and ADPKD, the disease that affected her father.
Federal health officials are expanding an investigation into potentially lead-tainted pouches of apple cinnamon fruit puree marketed for children amid reports of more illnesses and additional product recalls.
Kamili Bell Hill, author of "Happy Plants, Happy You: A Plant-Care & Self-Care Guide for the Modern Houseplant Parent," explains what you can do to make your houseplants thrive.
Marci Hopkins, recovery expert and author of "Chaos to Clarity: Seeing The Signs and Breaking The Cycles," talks about her own intergenerational experience with addiction that drove her to make changes and help others.
